| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.31 | 0.03 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |